The ACS Spectrum
Unstable Angina (UA)
NSTEMI
STEMI
Acute Coronary Syndrome (ACS) is an umbrella term for conditions caused by sudden reduction or blockage of coronary blood flow. All three subtypes share a common pathophysiological basis — atherosclerotic plaque disruption — but differ in severity of occlusion, myocardial damage, and ECG/biomarker findings.
Unstable Angina (UA)
- Chest pain at rest, new onset, or crescendo pattern
- No troponin rise — no myocardial necrosis
- ECG: ST depression, T-wave changes, or normal
- Partial occlusion or spasm with intact flow
NSTEMI
- Ischaemia severe enough to cause myocardial necrosis
- Troponin rise (hs-troponin above 99th percentile URL)
- ECG: ST depression, T-wave inversion, or normal — no ST elevation
- Partial occlusion or total occlusion of non-dominant vessel
STEMI
- Complete occlusion of major coronary artery — transmural ischaemia
- ECG: new ST elevation meeting voltage criteria (see below)
- Troponin will rise but diagnosis and treatment are ECG-driven — do NOT wait for troponin
- Time-critical: every minute of occlusion = ~2 million cardiomyocytes lost
Pathophysiology: Plaque Rupture to Occlusion
Step 1 — Vulnerable Plaque
Lipid-rich, thin-cap atherosclerotic plaque develops in coronary artery. Inflammation weakens fibrous cap. Shear stress, HTN, smoking accelerate cap thinning.
Step 2 — Plaque Rupture / Erosion
Cap ruptures or erodes, exposing lipid core and subendothelial collagen. This is not always flow-limiting prior to rupture — 70% of STEMIs occur from plaques with <50% stenosis.
Step 3 — Platelet Activation & Aggregation
Platelets adhere to exposed collagen via GP Ib-IX-V. Activation triggers ADP, TXA2 release amplifying aggregation. GP IIb/IIIa receptor mediates fibrinogen cross-linking.
Step 4 — Thrombus Formation
Coagulation cascade activated. Fibrin mesh reinforces platelet plug. Thrombus can be partially or fully occlusive — determines UA vs NSTEMI vs STEMI.
Step 5 — Ischaemia → Necrosis
Downstream myocardium deprived of oxygen. If flow not restored: subendocardial (NSTEMI) → transmural necrosis (STEMI). Wave-front phenomenon: necrosis begins within 20-40 min of occlusion.
STEMI ECG Diagnostic Criteria
⚠Diagnostic Criteria: New ST elevation at J-point in ≥2 contiguous leads: ≥1mm in ≥2 contiguous limb leads (I, II, III, aVF, aVL) OR ≥2mm in ≥2 contiguous chest leads (V1-V6). New Left Bundle Branch Block (LBBB) should be treated as STEMI equivalent.
| Territory | Culprit Artery | ECG Leads | Key Concerns |
|---|
| Anterior / Anteroseptal | LAD (Left Anterior Descending) | V1–V4 | Largest territory, highest mortality, cardiogenic shock risk |
| Lateral | LCx (Left Circumflex) | I, aVL, V5–V6 | Often associated with mitral regurgitation |
| Inferior | RCA (Right Coronary Artery) | II, III, aVF | Always rule out RV involvement — get right-sided leads |
| Posterior | RCA / LCx | V7–V9 (tall R waves + ST depression V1–V2) | Mirror image in V1-V2; get 18-lead ECG |
| Right Ventricle | Proximal RCA | V3R–V4R (ST elevation) | Preload-dependent — avoid nitrates, cautious with diuretics |
ⓘNew LBBB: Sgarbossa criteria used if LBBB present: concordant ST elevation ≥1mm in leads with positive QRS (5 points), concordant ST depression ≥1mm in V1–V3 (3 points), excessively discordant ST elevation ≥5mm (2 points). Score ≥3 = 90% specificity for AMI.
Cardiac Biomarkers
High-Sensitivity Troponin (hs-TnI / hs-TnT)
- Gold standard for myocardial necrosis detection
- Rises: 3–6 hours after symptom onset
- Peaks: 12–24 hours
- Returns to normal: 10–14 days
- 0/1-hour or 0/3-hour rapid rule-out protocols recommended by ESC guidelines
- Positive = level above 99th percentile Upper Reference Limit (URL)
0/1-Hour Protocol (ESC)
- Rule-OUT: hs-Tn at 0h very low AND 1h delta minimal → discharge with low-risk workup
- Rule-IN: hs-Tn at 0h very high OR 1h delta large → NSTEMI confirmed
- Observe: intermediate values → 3h sample required
CK-MB (Creatine Kinase-MB)
- Rises 4–8h, peaks 10–24h, normalises in 48–72h
- Shorter half-life than troponin makes it useful for re-infarction detection
- If new chest pain after ACS: fresh CK-MB rise while troponin remains elevated = reinfarction
Other Biomarkers
- Myoglobin: earliest rise (1–3h) — low specificity; not commonly used
- BNP/NT-proBNP: elevated in HF complicating ACS — guides management
- D-dimer: rule out PE in atypical chest pain presentations
ⓘNever delay STEMI reperfusion to wait for troponin results. ECG drives the diagnosis in STEMI.
GCC ACS Epidemiology
10yrs
GCC males present with MI ~1 decade earlier than Western counterparts
60%
Prevalence of diabetes mellitus among GCC ACS patients (GULF RACE data)
50%
Estimated smoking prevalence in young GCC male ACS patients
- Young MI phenotype: Males in their 30s–40s presenting with STEMI are disproportionately common in GCC compared to Western registries
- Key drivers: Type 2 diabetes mellitus (poorly controlled, high HbA1c), heavy cigarette and shisha smoking, strong family history, sedentary lifestyle, visceral obesity
- GULF RACE Registry: Gulf Registry of Acute Coronary Events — landmark multinational study across GCC documenting ACS presentation patterns, outcomes, and treatment gaps
- Female underrepresentation: Women present later, with more atypical symptoms, and have higher in-hospital mortality — may be under-referred for angiography
PQRST Pain Assessment
| Letter | Question | ACS Red Flags |
|---|
| P — Provocation | What makes it better or worse? | Pain at rest OR with minimal exertion; NOT relieved by GTN in STEMI |
| Q — Quality | How would you describe the pain? | Pressure, tightness, crushing, "elephant sitting on chest", heaviness, burning |
| R — Radiation | Does it go anywhere? | Radiation to left arm, jaw, neck, right arm, between shoulder blades |
| S — Severity | Score 0–10 | Often 7–10/10 in STEMI; note: diabetics/elderly may under-rate or have no pain |
| T — Timing | When did it start? Is it constant or intermittent? | Constant pain >20 min at rest = ACS until proven otherwise; note exact onset for reperfusion timing |
Atypical ACS Presentations — Do Not Miss
⚠Up to 30% of ACS patients present without classic chest pain. Atypical presentations are more common in women, elderly patients, and diabetics — these groups have higher mortality due to delayed recognition.
Women
- Nausea and vomiting
- Fatigue (unusual, unexplained)
- Shortness of breath
- Jaw or neck pain
- Epigastric discomfort
- Palpitations
Elderly (>75 years)
- Syncope or collapse
- Acute confusion / delirium
- Weakness or fatigue
- Dyspnoea as predominant symptom
- Silent MI (no symptoms at all)
Diabetics
- Silent MI (autonomic neuropathy)
- Epigastric pain only
- Unexplained hyperglycaemia
- Dyspnoea without chest pain
- Sweating and nausea
HEART Score — Risk Stratification Tool
The HEART score is validated for emergency chest pain assessment. Each component scored 0, 1, or 2. Total 0–10.
| Component | 0 Points | 1 Point | 2 Points |
|---|
| H — History | Slightly suspicious — atypical features | Moderately suspicious | Highly suspicious — classic ACS features |
| E — ECG | Normal | Non-specific repolarisation disturbance | Significant ST deviation (LBBB, ST depression/elevation) |
| A — Age | <45 years | 45–64 years | ≥65 years |
| R — Risk Factors | No known risk factors | 1–2 risk factors OR obesity (BMI >30) | ≥3 risk factors OR known atherosclerotic disease |
| T — Troponin | ≤Normal limit | 1–3x normal limit | >3x normal limit |
0–3
LOW risk — 1.7% 6-week MACE — consider discharge with outpatient follow-up
4–6
MODERATE risk — 12% 6-week MACE — admit for observation, serial troponins, stress testing
7–10
HIGH risk — 65% 6-week MACE — early invasive strategy, cardiology review
12-Lead & 18-Lead ECG Acquisition
⏳Target: ECG within 10 minutes of patient contact (door-to-ECG). In STEMI, the 12-lead ECG is the single most important diagnostic action. Do not delay for history, cannulation, or undressing.
Standard 12-Lead Placement
- Patient supine, limbs relaxed, minimal muscle tension
- Limb leads: RA, LA, RL, LL — avoid bony prominences, ensure good contact
- Precordial leads: V1 — 4th ICS, right sternal border; V2 — 4th ICS, left sternal border; V3 — between V2 and V4; V4 — 5th ICS, midclavicular line; V5 — anterior axillary line (same level as V4); V6 — midaxillary line (same level as V4–V5)
- Reduce artefact: still patient, warm skin, clean and dry
Extended 18-Lead ECG — When to Do It
- Posterior STEMI (V7–V9): ST depression in V1–V3 with tall R waves — roll patient slightly left, place V7 (posterior axillary line), V8 (inferior angle of scapula), V9 (left paraspinal) at same level as V6
- RV Infarction (V3R–V4R): Any inferior STEMI (II, III, aVF) — place right-sided V3R and V4R (mirror image positions on right chest)
- RV infarction: ST elevation ≥1mm in V4R is highly specific — critical as management differs (nitrates contraindicated)
Immediate Nursing Actions — MONA
| MONA | Action | Notes |
|---|
| M — Morphine | 2–5mg IV titrated for pain | Use cautiously — may mask symptoms, potential negative interaction with P2Y12 inhibitors (delayed absorption). Consider fentanyl alternative. |
| O — Oxygen | Only if SpO2 <94% | Hyperoxia is harmful in ACS. Target SpO2 94–98% (or 88–92% if COPD). Do NOT give routine O2. |
| N — Nitrates | GTN 0.4mg SL / IV infusion | Contraindicated in RV infarction, systolic BP <90mmHg, recent PDE5 inhibitor use (sildenafil within 24h, tadalafil within 48h) |
| A — Aspirin | 300mg oral loading dose | Chewed (not swallowed whole) for faster absorption. Give immediately unless true allergy. First and most time-sensitive antiplatelet. |
Additional Immediate Actions
Reperfusion Time Targets
<90 min
Door-to-Balloon (D2B) target — primary PCI from first medical contact to wire crossing
<30 min
Door-to-Needle — thrombolysis when primary PCI unavailable or transfer >120 min
<120 min
Maximum acceptable delay if transferring to PCI-capable centre from non-PCI site
⚠Time = Myocardium: Every 30-minute delay in reperfusion increases 1-year mortality by ~7.5%. Nursing actions that shorten door-to-balloon time save lives. Prioritise parallel processing over sequential steps.
Code STEMI — Parallel Processing
Traditional sequential processing (assess → call doctor → get ECG → call cardiology → activate lab) is too slow. Parallel processing means multiple actions happen simultaneously.
Simultaneous Actions (Do All at Once)
- ECG acquisition and transmission to cardiologist
- Nurse 1: IV access, bloods, aspirin administration
- Nurse 2: Call cardiology/cath lab activation line
- Nurse 3: Patient preparation (see checklist below)
- Ward clerk/team: Call patient's family, gather consent forms
- Pharmacist/nurse: Prepare heparin bolus and dual antiplatelet
Communication — Code STEMI Call
When activating cath lab, communicate clearly:
- STEMI confirmed on ECG (state which territory)
- Time of symptom onset and door time
- Patient age, weight, allergies
- Haemodynamic status (BP, HR, signs of shock)
- Current medications already given
- Anticipated access site preference (radial vs femoral)
Dual Antiplatelet Therapy (DAPT) — Pre-PCI Loading
ⓘDAPT loading should be given as early as possible, ideally in the ED before transfer to cath lab. Do not delay PCI for DAPT if loading can be given en route.
| Drug | Loading Dose | Timing | Key Nursing Points |
|---|
| Aspirin | 300mg PO (chewed) | Immediately on diagnosis | First antiplatelet. Check allergy. Fastest absorption when chewed vs swallowed. |
| Ticagrelor (preferred) | 180mg PO (two 90mg tablets) | Before PCI or at diagnosis | Preferred P2Y12 agent. Reversible, faster onset. Side effect: dyspnoea (usually self-limiting, not bronchospasm). Avoid if history of intracranial haemorrhage. |
| Prasugrel | 60mg PO | After coronary anatomy known (usually in cath lab) | More potent than clopidogrel. Contraindicated: age >75, weight <60kg, prior stroke/TIA. Use when ticagrelor not tolerated. |
| Clopidogrel | 600mg PO | If ticagrelor/prasugrel unavailable or contraindicated | Third-line P2Y12. CYP2C19 polymorphism affects efficacy. Widely used in GCC due to cost. |
Heparin & Anticoagulation for Primary PCI
- Unfractionated Heparin (UFH): 70–100 units/kg IV bolus (max 10,000 units) given before/during PCI — reduces thrombus burden and prevents catheter thrombosis
- Weight-based calculation: confirm patient weight before drawing up; double-check with second nurse if time permits
- Bivalirudin (direct thrombin inhibitor) may be used as alternative — lower bleeding risk, especially for high-bleeding-risk patients
- Anticoagulation given intra-procedurally by cardiologist/perfusionist — nurse role is preparation and documentation
Patient Preparation for Catheterisation — Checklist
ⓘThrombolysis Indication: If primary PCI is unavailable and transfer time >120 minutes, thrombolysis with tenecteplase (TNK) is indicated. Nurse role: confirm no absolute contraindications (prior ICH, recent surgery, active bleeding, BP >180/110), draw up weight-based dose, prepare fibrinolytic checklist, document time of lytic administration precisely.
Radial Access Site Care — TR Band Protocol
ⓘPatent Haemostasis: The goal is haemostasis while maintaining radial artery patency. Confirmed by: compression band inflated just enough to stop bleeding while ulnar pulse remains palpable — do NOT over-compress.
TR Band (Terumo Radial) Deflation Protocol
- Initial inflation: per procedure protocol (usually 13–15mL air)
- Deflate 2mL every 2 hours (or per unit protocol, commonly 1–2mL per step)
- Before EACH deflation: check radial pulse at wrist — if absent, do NOT deflate further; notify cardiologist
- After final deflation: leave band in place for 30 min, then remove if no ooze
- Typical total removal time: 4–6 hours post-procedure
Nursing Monitoring — Radial Site
- Check access site and forearm for haematoma, swelling, discolouration every 30 min while band in situ
- Monitor hand perfusion: capillary refill, temperature, sensation every check
- Arm elevation (pillow support) reduces oedema and aids haemostasis
- Patient education: avoid bending wrist, no heavy lifting affected arm for 24 hours
⚠Radial Artery Occlusion Risk: Occurs in 1–5%. Risk reduced by patent haemostasis protocol. If hand cold, pale, paraesthesia → loosen band immediately → vascular/cardiology review.
Femoral Access Site Care
Immediate Post-Sheath Removal
- Manual pressure over femoral artery for 10–20 minutes (longer if on heparin or IIb/IIIa)
- Mechanical compression device (FemoStop, C-clamp) if available
- Pressure dressing applied after haemostasis achieved
- Leg kept flat and straight for 2–6 hours (per unit protocol)
- No hip flexion >30 degrees during bed rest period
Neurovascular Checks
- Every 15 minutes for first hour, then every 30–60 min
- Check: pulses (DP/PT), temperature, colour, capillary refill, sensation, movement of foot
- Compare bilateral lower limbs
- Document findings each check
Haematoma Grading & Response
| Grade | Description | Action |
|---|
| I | <5cm bruising/swelling | Monitor, document |
| II | 5–10cm haematoma | Prolonged manual pressure, review anticoagulation |
| III | >10cm expanding | Urgent — firm compression, notify cardiologist, IV access, bloods |
| IV | Retroperitoneal | Emergency — see below |
⚠Retroperitoneal Haematoma: Flank/back pain, hypotension, tachycardia, falling Hb, expanding abdomen — often WITHOUT visible groin haematoma. This is a life-threatening emergency. Call for emergency help immediately, large-bore IV, IV fluids, urgent CT abdomen, prepare for possible transfusion/intervention.
Post-PCI Arrhythmia Monitoring
Reperfusion Arrhythmias (Expected)
- AIVR (Accelerated Idioventricular Rhythm): Wide complex rhythm, rate 60–110 bpm, occurs within minutes of reperfusion. BENIGN — marker of successful reperfusion. No treatment required — observe and document.
- Sinus bradycardia: Common with inferior STEMI (vagal tone). Treat only if symptomatic (atropine 0.5mg IV).
- PVCs: Common post-PCI — isolated PVCs in reperfusion context are benign.
Concerning Arrhythmias (Require Action)
- Ventricular Tachycardia (VT): Sustained VT post-PCI requires urgent treatment. If haemodynamically unstable → synchronised cardioversion. Stable VT → amiodarone IV per protocol.
- Ventricular Fibrillation (VF): Immediate defibrillation — 200J biphasic. Ensure crash cart at bedside for all post-STEMI patients in first 24 hours.
- Complete Heart Block: More common with inferior/RV STEMI. May need temporary pacing. Avoid medications that slow AV conduction.
- Atrial Fibrillation: New AF post-MI carries high risk. Rate control first; anticoagulation considerations complex with existing DAPT.
No-Reflow Phenomenon
⚠No-reflow: Despite successful opening of the culprit artery, microvascular obstruction prevents tissue perfusion. Signs: persistent ST elevation post-PCI, new symptoms, haemodynamic deterioration, poor TIMI flow on angiogram. Requires urgent cardiologist review and potential re-catheterisation / intracoronary medication.
Nursing recognition: patient returns from cath lab, report was successful PCI, but patient continues to report pain, ECG shows persisting ST elevation, or haemodynamics worsen. Do not dismiss as anxiety — call cardiology immediately.
- Intracoronary adenosine, verapamil, or GP IIb/IIIa inhibitors may be given in cath lab
- Post-procedure ECG at 30 min and 60 min is essential to confirm ST resolution
- ST resolution >50% = marker of successful reperfusion
Post-PCI Medications — Patient Education
| Medication | Indication | Duration | Key Education Points |
|---|
| Aspirin 75–100mg daily | Antiplatelet — first line | Lifelong | Do NOT stop without cardiologist advice. Take with food. Stent thrombosis risk if stopped early. |
| Ticagrelor 90mg BD or Clopidogrel 75mg OD | DAPT — second antiplatelet | 12 months minimum after DES; review at 6m if high bleeding risk | NEVER miss a dose. Ticagrelor: avoid strong CYP3A4 inhibitors. Bleeding risk counselling. |
| High-intensity statin (Atorvastatin 40–80mg or Rosuvastatin 20–40mg) | Plaque stabilisation, LDL reduction | Lifelong | Target LDL <1.4 mmol/L. Take at night (atorvastatin anytime). Report muscle pain (myopathy). |
| Beta-blocker (Bisoprolol, Carvedilol, Metoprolol) | Reduces infarct remodelling, arrhythmia protection, HF benefit | Minimum 12 months; lifelong if LVEF <40% | Do not stop abruptly. Monitor HR and BP. Caution in reactive airway disease. |
| ACE inhibitor / ARB (Ramipril, Perindopril, Valsartan) | Reduces LV remodelling, BP control, HF prevention | Lifelong if LVEF reduced or DM or HTN | ACEi cough common — switch to ARB. Monitor renal function and potassium. Avoid in pregnancy. |
NSTEMI/UA — Conservative vs Invasive Strategy
Very High Risk — Immediate Angiography (<2 hours)
- Haemodynamic instability or cardiogenic shock
- Refractory chest pain despite medical treatment
- Life-threatening arrhythmias (VT/VF)
- Acute heart failure with NSTEMI
- Mechanical complications (new MR, VSR)
- Transient ST elevation or recurrent dynamic ECG changes
High Risk — Early Angiography (<24 hours)
- Significant troponin rise/fall meeting NSTEMI criteria
- Dynamic ST or T-wave changes
- GRACE score >140
- Resuscitated cardiac arrest without ST elevation on ECG
Intermediate Risk — 24–72 hours
- Diabetes mellitus
- Renal insufficiency (eGFR <60)
- LVEF <40% or HF
- Prior PCI or CABG
- GRACE score 109–140
Risk Scores — TIMI and GRACE
TIMI Risk Score for UA/NSTEMI (0–7)
| Factor | Points |
|---|
| Age ≥65 years | 1 |
| ≥3 CAD risk factors | 1 |
| Known coronary stenosis ≥50% | 1 |
| ST deviation on presenting ECG | 1 |
| ≥2 anginal events in prior 24 hours | 1 |
| Aspirin use in prior 7 days | 1 |
| Elevated serum cardiac markers | 1 |
Score 0–2: low (5% MACE at 14 days) | 3–4: intermediate (13%) | 5–7: high (26%)
GRACE 2.0 Score
More complex score using: age, creatinine, SBP, HR, Killip class, cardiac arrest, ST deviation, elevated troponin. Calculates 6-month mortality risk. Widely used in European/GCC guidelines.
- Low risk: GRACE <109 — <1% in-hospital mortality
- Intermediate: GRACE 109–140
- High risk: GRACE >140 — >3% in-hospital mortality
ⓘGRACE score is preferred by ESC guidelines. Use validated online calculator. Nursing role: ensure accurate vital signs and initial troponin input for correct score.
Anticoagulation in NSTEMI/UA
| Agent | Dose | Notes |
|---|
| Fondaparinux 2.5mg SC daily | Fixed dose — no weight adjustment | Preferred agent (ESC) — lowest bleeding profile. Indirect Xa inhibitor. Add UFH bolus if proceeding to PCI (fondaparinux insufficient intra-procedure catheter protection). |
| Enoxaparin (LMWH) | 1mg/kg SC every 12 hours; reduce to 1mg/kg OD if eGFR <30 ml/min | Weight-based — confirm weight. Renal dose adjustment essential. Monitor anti-Xa if obese or renal impairment. No anti-Xa monitoring with standard dosing. |
| UFH IV infusion | 60 units/kg bolus then 12 units/kg/hr — aPTT 50–70s | Used if proceeding to early PCI, renal failure (eGFR <15), or when rapid reversal needed. Requires 6-hourly aPTT monitoring until therapeutic. |
| Bivalirudin | 0.75mg/kg IV bolus, 1.75mg/kg/hr infusion during PCI | Alternative to UFH for PCI — lower major bleeding risk. Short half-life. |
⚠Enoxaparin Renal Dosing: Always check eGFR before first dose. eGFR 15–30 → 1mg/kg OD. eGFR <15 → avoid; use UFH. Elderly patients often have low eGFR despite normal creatinine due to reduced muscle mass — calculate eGFR, do not estimate from creatinine alone.
GP IIb/IIIa Inhibitors
Agents Used in GCC
- Eptifibatide (Integrilin): 180 mcg/kg IV bolus, then 2 mcg/kg/min infusion for 18–72h (reduce infusion in renal impairment)
- Tirofiban (Aggrastat): 25 mcg/kg IV bolus over 3 min, then 0.15 mcg/kg/min infusion for 12–24h
- Abciximab: less commonly used now; mainly intracoronary during PCI
Indications
- High-risk NSTEMI proceeding to PCI with elevated troponin
- No pre-treatment with P2Y12 inhibitor
- Angiographic evidence of high thrombus burden
Nursing Monitoring — IIb/IIIa Infusion
- Dedicated IV line — do not co-infuse with other drugs without pharmacist check
- Bleeding monitoring every 1–2 hours: access sites, gingival, haematuria, melena
- Platelet count at 4h and 24h after initiation (thrombocytopaenia risk)
- Avoid IM injections and arterial punctures during infusion
- Blood pressure monitoring — hypotension can occur
- Stop infusion if: active bleeding, platelet count <100,000, urgent surgery required
⚠Acute Profound Thrombocytopaenia (platelet <20,000) is a rare but serious complication. Stop infusion immediately, check platelet count urgently, notify physician.
NSTEMI Complications Monitoring
Re-infarction Signs
- New or recurrent chest pain after initial stabilisation
- Fresh ST elevation or new ECG changes
- Rising CK-MB (while troponin still elevated from index event)
- New haemodynamic deterioration
- Action: 12-lead ECG immediately, senior review, may trigger urgent angiography
Acute Heart Failure Monitoring
- Worsening dyspnoea, falling SpO2, new crepitations on auscultation
- Rising BNP/NT-proBNP
- Fluid balance deterioration, rising JVP
- New S3 gallop or mitral regurgitation murmur
Mechanical Complications (Rare but Life-Threatening)
- Papillary muscle rupture: New loud mitral regurgitation murmur, acute pulmonary oedema, haemodynamic collapse — usually day 2–5
- Ventricular septal rupture (VSR): New harsh holosystolic murmur at left sternal edge, biventricular failure, right heart strain on ECG — requires emergency surgical repair
- Free wall rupture: Sudden haemodynamic collapse, electromechanical dissociation (PEA) — usually fatal. Risk highest days 3–5 post-STEMI with full-thickness necrosis.
⚠Any new loud systolic murmur in an ACS patient = mechanical complication until proven otherwise. Immediate echocardiogram and senior cardiologist review.
GCC-Specific Risk Factor Profile
~20%
Prevalence of T2DM in Gulf region (one of highest globally — IDF data)
30–40s
Typical age of STEMI in GCC young male patients vs 50–60s in Western cohorts
40%
Male smoking prevalence in some GCC countries (WHO estimates)
Primary Risk Factors in GCC
- Type 2 Diabetes Mellitus: Highest global prevalence in Gulf. Often poorly controlled at ACS presentation. Contributes to endothelial dysfunction, accelerated atherosclerosis, and atypical MI presentations.
- Cigarette Smoking: High rates among GCC males, especially migrant worker populations. Direct platelet activating effect, endothelial injury, coronary vasospasm.
- Shisha/Hookah Smoking: Perceived as less harmful but a single shisha session delivers equivalent carbon monoxide to multiple cigarettes. Acute vasospasm and haemoglobin dysfunction.
- Obesity and Physical Inactivity: Rapid dietary Westernisation combined with sedentary culture and extreme heat discouraging outdoor exercise.
Other Contributing Factors
- Strong Family History: Genetic predisposition to early atherosclerosis noted in South Asian and Arab populations — polygenic risk compounding lifestyle factors
- Hypertension: Prevalent and often undiagnosed until ACS presentation; poor medication adherence common
- Psychosocial Stress: Work pressure, financial stress, displacement among migrant workers — chronic cortisol elevation and sympathetic activation
- Dyslipidaemia: High-fat diet transition, low HDL common in GCC populations
- Late Presentation: Cultural stoicism, avoidance of hospital — patients often present hours after symptom onset, reducing reperfusion success
Ramadan and Acute Coronary Syndrome
☽Multiple studies including GULF RACE data show increased ACS incidence during Ramadan, with peak in the first week of fasting. Nurses must be aware of religious context to provide culturally competent, evidence-based care.
Physiological Stressors During Ramadan
- Dehydration: No fluid intake 12–16+ hours; exacerbated by hot GCC climate. Haemoconcentration increases blood viscosity and thrombotic risk.
- Circadian Disruption: Late-night eating, altered sleep patterns, prolonged evening activity — sympathetic activation and cortisol rhythm disruption
- Meal Pattern: Large high-fat Iftar and Suhoor meals with long fasting intervals — postprandial lipidaemia and hyperglycaemia spikes
- Glycaemic instability: Diabetics adjust insulin/OHA timing — risk of hypoglycaemia and rebound hyperglycaemia both contributing to cardiovascular stress
Medication Non-Compliance During Ramadan
- Patients often stop medications fearing invalidation of fast (incorrect belief — most medications do not break fast)
- Antihypertensives, beta-blockers, antiplatelets — stopping abruptly dangerous
- Nursing role: Pre-Ramadan medication counselling; reassure patients most oral medications are permissible; involve religious advisors if needed
- Post-ACS patients who are devout: counsel that Islam permits breaking fast for illness — quote Islamic principle of necessity (darura)
Post-ACS Ramadan Guidance
- No fasting recommended within 3 months of ACS without cardiologist clearance
- If fasting: increase fluid intake at night, adjust medication timing, increase monitoring frequency, have clear action plan if symptoms recur
Cocaine/Substance-Associated ACS
ⓘCocaine use in the GCC is underreported due to social stigma and legal consequences, but it is present. Nurses should be non-judgmental and maintain clinical suspicion in young ACS patients with no traditional risk factors.
Mechanism of Cocaine-Associated MI
- Coronary vasospasm (alpha-adrenergic stimulation)
- Accelerated atherosclerosis in chronic users
- Platelet aggregation and thrombus formation
- Hypertensive surge with tachycardia — increased myocardial oxygen demand
- Can occur with or without underlying coronary disease
Clinical Clues and Nursing Actions
- Young patient, no risk factors, STEMI or vasospastic pattern
- Associated hypertension, agitation, dilated pupils, epistaxis
- Urine toxicology screen (cocaine metabolites detectable 2–4 days)
- Avoid beta-blockers in cocaine-associated ACS (unopposed alpha stimulation worsens vasospasm)
- Benzodiazepines first-line for agitation and sympatholysis
- GTN and calcium channel blockers for vasospasm
- Confidential, non-judgmental communication with patient
Primary PCI Networks in GCC
Qatar
- Hamad Heart Institute (HHI), Doha: 24/7 primary PCI, one of busiest cardiac centres in the region. Established Code STEMI protocol with EMS pre-notification and direct cath lab activation from ambulance.
- Qatar Ambulance Service (Hamad Medical Corporation) provides pre-hospital 12-lead ECG with telemetry transmission to HHI.
UAE
- Dubai: Multiple PCI-capable centres including Cleveland Clinic Abu Dhabi, American Hospital Dubai, Rashid Hospital (Dubai Health Authority)
- Abu Dhabi: Sheikh Khalifa Medical City, Cleveland Clinic Abu Dhabi — 24/7 STEMI networks
Saudi Arabia
- Riyadh: King Faisal Specialist Hospital (KFSH&RC), Prince Sultan Cardiac Centre — tertiary cardiac facilities
- National guard hospitals and MOH hospitals with expanding PCI capability
- Saudi Heart Association guidelines align with ESC recommendations
Bahrain, Kuwait, Oman
- Each country has national cardiac centres providing PCI capability with variable 24/7 coverage
- Smaller hospitals may require transfer to PCI centre — nurses must know local transfer protocol and thrombolysis criteria if transfer >120 min
GULF RACE Registry
The Gulf Registry of Acute Coronary Events (GULF RACE) is the landmark multicountry registry documenting ACS presentations, management, and outcomes across GCC countries (Saudi Arabia, UAE, Qatar, Bahrain, Kuwait, Oman, Yemen).
Key GULF RACE Findings
- GCC ACS patients are significantly younger than Western cohorts
- Higher prevalence of DM, smoking at presentation
- Longer symptom-to-door times compared to Western registries — reflects late health-seeking behaviour
- Lower use of evidence-based medications at discharge than international benchmarks (improving with registry feedback)
- Women had higher in-hospital mortality and were less likely to receive invasive management
Implications for Nursing Practice
- Public education campaigns vital — nurses are frontline community educators
- Faster door-to-ECG and door-to-balloon times remain improvement targets
- Discharge medication counselling essential — registry shows gaps in secondary prevention
- Female ACS patients need particular attention — higher atypical presentation rate and under-treatment
- Cardiac rehabilitation referral rates remain low — nurses must advocate for CR referral at discharge
Cardiac Rehabilitation in GCC
⚠Cardiac rehabilitation (CR) completion rates in GCC remain significantly below international targets. GULF RACE and subsequent data show <20% of eligible ACS patients completing structured CR programmes despite Level I evidence for mortality benefit.
Barriers to CR in GCC
- Low physician referral rates at discharge
- Limited awareness among patients of CR benefits
- Cultural barriers: gender-mixed exercise programmes unacceptable to some female patients
- Heat and climate limiting outdoor activity
- Migrant worker populations: lack of insurance, language barriers, work obligations
- Limited CR programme availability outside major cities
Nursing Role in CR Promotion
- Initiate CR discussion before discharge — do not assume cardiologist will refer
- Provide written CR information in Arabic and relevant languages
- Emphasise 26% relative risk reduction in cardiovascular mortality with CR
- Address gender concerns: women-only CR sessions available at some centres
- Home-based or telehealth CR as alternative where facility-based not feasible
- Follow-up phone call within 1 week of discharge to check CR enrolment